Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Announces Two New Grant Awards of $2 Million Each

SBIR Phase II Grants bring the cumulative grant total to approximately $17 million from the National Institutes of Health and National Cancer InstituteCORALVILLE, IA / ACCESSWIRE / October 11, 2022 / Viewpoint

Related Keywords

Thijs Spoor ,Kostenloser Wertpapierhandel ,Michaelk Schultz ,Francesl Johnson ,National Cancer Institute ,Exchange Commission On ,Small Business Innovation Research ,National Institutes Of Health ,University Of Iowa ,Viewpoint Molecular Targeting Inc ,Isoray Inc ,National Institutes ,National Cancer ,Viewpoint Molecular Targeting ,Chief Scientific Officer ,Chief Operating ,Molecular Targeting ,Viewpoint Molecular ,Exchange Commission ,Securities Litigation Reform Act ,Public Relations ,Viewpoint ,Olecular ,Targeting ,Nnounces ,Rant ,Awards ,Billion ,Peach ,